Skip to main content
European Commission logo print header

Liver steatosis drives muscle atrophy in type 2 diabetes patients.

Publications

Mitochondrial Dysfunction is a Key Pathway that Links Saturated Fat Intake to the Development and Progression of NAFLD

Author(s): Ruth C. R. Meex, Ellen E. Blaak
Published in: Molecular Nutrition & Food Research, Issue 65/1, 2021, Page(s) 1900942, ISSN 1613-4125
Publisher: John Wiley & Sons Ltd.
DOI: 10.1002/mnfr.201900942

Hepatic Steatosis Contributes to the Development of Muscle Atrophy via Inter-Organ Crosstalk

Author(s): Kenneth Pasmans, Michiel E Adriaens, Peter Olinga, Ramon Langen, Sander S Rensen, Frank G Schaap, Steven W M Olde Damink, Florian Caiment, Luc J C van Loon, Ellen E Blaak, Ruth C R Meex
Published in: Frontiers in Endocrinology, 2021, ISSN 1664-2392
Publisher: Frontiers in Endocrinology
DOI: 10.3389/fendo.2021.733625

Lipotoxicity plays a key role in the development of both insulin resistance and muscle atrophy in patients with type 2 diabetes

Author(s): Ruth C.R. Meex, Ellen E. Blaak, Luc J.C. Loon
Published in: Obesity Reviews, Issue 20/9, 2019, Page(s) 1205-1217, ISSN 1467-7881
Publisher: Blackwell Publishing Inc.
DOI: 10.1111/obr.12862

Mitochondrial dysfunction-related lipid changes occur in nonalcoholic fatty liver disease progression

Author(s): Kang-Yu Peng, Matthew J. Watt, Sander Rensen, Jan Willem Greve, Kevin Huynh, Kaushala S. Jayawardana, Peter J. Meikle, Ruth C.R. Meex
Published in: Journal of Lipid Research, Issue 59/10, 2018, Page(s) 1977-1986, ISSN 0022-2275
Publisher: Lipid Research, Inc.
DOI: 10.1194/jlr.m085613

Searching for OpenAIRE data...

There was an error trying to search data from OpenAIRE

No results available